Proliferating bone marrow precursors (""""""""stem cells"""""""") differentiate to produce mature hematopoietic cells. The molecular controls governing commitment to and differentiation of the myeloid (granulocyte/monocyte) lineage, the lineage in which a block in differentiation results in over 90% of acute leukemias in adults, have not been fully elucidated. One hypothesis is that the expression of lineage specific transcription factors play a major role in commitment and differentiation. The overall goal of this continuation proposal is to continue to study how factors such as PU.1 regulate the expression of the gene encoding CD11b (Mac-1 alpha), a cell surface adhesion protein which is specifically expressed in myeloid cells and strongly up-regulated during the course of human myeloid differentiation as a model to understand (1) commitment of normal hematopoietic precursors to the myeloid lineage; and (2) the process of normal myeloid maturation from myeloid blasts to mature myeloid cells, a process which is blocked in acute myelogenous leukemia (AML). Therefore, in order to further characterize the molecular mechanisms of the regulation and expression of the CD11b gene in myeloid cells, and the role of the PU.1 transcription factor in myeloid commitment and differentiation, we propose the following specific aims: (1) To determine if the PU.1 and Sp1 transcription factors function as important determinants of the myeloid specific expression of the CD11b promoter in ES cells and transgenic mice; (2) To determine the expression pattern of the PU.1 protein during myeloid commitment, and the molecular controls of the regulation of PU.1 expression; and (3) T determine the importance of the PU.1 factor in vivo for CD11b expression, myeloid lineage commitment, and differentiation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA041456-14
Application #
2766687
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Mufson, R Allan
Project Start
1986-01-01
Project End
2003-12-31
Budget Start
1999-01-01
Budget End
1999-12-31
Support Year
14
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Welner, Robert S; Bararia, Deepak; Amabile, Giovanni et al. (2013) C/EBP? is required for development of dendritic cell progenitors. Blood 121:4073-81
Ye, Min; Zhang, Hong; Amabile, Giovanni et al. (2013) C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nat Cell Biol 15:385-94
Staber, Philipp B; Zhang, Pu; Ye, Min et al. (2013) Sustained PU.1 levels balance cell-cycle regulators to prevent exhaustion of adult hematopoietic stem cells. Mol Cell 49:934-46
Zhang, Yue; Yan, Xiaomei; Sashida, Goro et al. (2012) Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells. Blood 120:1118-29
Leddin, Mathias; Perrod, Chiara; Hoogenkamp, Maarten et al. (2011) Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells. Blood 117:2827-38
Huang, Gang; Zhao, Xinghui; Wang, Lan et al. (2011) The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations. Blood 118:6544-52
Levantini, Elena; Lee, Sanghoon; Radomska, Hanna S et al. (2011) RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element. EMBO J 30:4059-70
Aikawa, Yukiko; Katsumoto, Takuo; Zhang, Pu et al. (2010) PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2. Nat Med 16:580-5, 1p following 585
Hoogenkamp, Maarten; Lichtinger, Monika; Krysinska, Hanna et al. (2009) Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program. Blood 114:299-309
Ueno, S; Tatetsu, H; Hata, H et al. (2009) PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL. Oncogene 28:4116-25

Showing the most recent 10 out of 73 publications